Blood Tests Designed to Minimize Unnecessary Biopsies
Chronix Biomedical has been developing blood tests that can be used for important applications in cancer and organ transplantation. Second Opinion™ Supplementary Tests are laboratory developed tests used to help clinicians in the decision making process of whether a patient with a positive cancer screening test should be given a tissue biopsy. The first Second Opinion™ tests are designed to bring down the unacceptably high number of false positives for both PSA testing for prostate cancer and mammograms for breast cancer.
Chronix Biomedical At ASCO
Listen to Chronix Biomedical Talk About a Study to Predict Treatment Outcomes in Cancer
Chronix Biomedical was honored to receive a Distinguished Abstract Award for it new blood test for transplant organ rejection using the Bio-rad Droplet Digital PCR technology.
Click here to view the 2008 Nobel Prize winner, Luc Montagnier, Chronix CEO, Howard Urnovitz and Prairie Gold General Partner, Mike Jerstad discuss how the academic, business and financial sectors can work together to fight breast cancer